RS57877B1 - Metoda za lečenje osteoporoze - Google Patents

Metoda za lečenje osteoporoze

Info

Publication number
RS57877B1
RS57877B1 RS20181177A RSP20181177A RS57877B1 RS 57877 B1 RS57877 B1 RS 57877B1 RS 20181177 A RS20181177 A RS 20181177A RS P20181177 A RSP20181177 A RS P20181177A RS 57877 B1 RS57877 B1 RS 57877B1
Authority
RS
Serbia
Prior art keywords
treating osteoporosis
osteoporosis
treating
Prior art date
Application number
RS20181177A
Other languages
English (en)
Inventor
Martin Javier San
Scott Wasserman
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of RS57877B1 publication Critical patent/RS57877B1/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Removal Of Specific Substances (AREA)
RS20181177A 2011-04-19 2012-04-18 Metoda za lečenje osteoporoze RS57877B1 (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161477065P 2011-04-19 2011-04-19
PCT/US2012/034107 WO2012145417A1 (en) 2011-04-19 2012-04-18 Method for treating osteoporosis
EP12717002.5A EP2699261B1 (en) 2011-04-19 2012-04-18 Method for treating osteoporosis

Publications (1)

Publication Number Publication Date
RS57877B1 true RS57877B1 (sr) 2018-12-31

Family

ID=46000402

Family Applications (2)

Application Number Title Priority Date Filing Date
RS20181177A RS57877B1 (sr) 2011-04-19 2012-04-18 Metoda za lečenje osteoporoze
RS20201149A RS60835B1 (sr) 2011-04-19 2012-04-18 Metoda za lečenje osteoporoze

Family Applications After (1)

Application Number Title Priority Date Filing Date
RS20201149A RS60835B1 (sr) 2011-04-19 2012-04-18 Metoda za lečenje osteoporoze

Country Status (15)

Country Link
US (1) US20140127192A1 (sr)
EP (2) EP2699261B1 (sr)
AU (1) AU2012245495A1 (sr)
CA (1) CA2833289A1 (sr)
CY (2) CY1121527T1 (sr)
DK (2) DK2699261T3 (sr)
ES (2) ES2823240T3 (sr)
HR (2) HRP20181649T1 (sr)
HU (1) HUE052094T2 (sr)
LT (2) LT3404041T (sr)
PL (2) PL2699261T3 (sr)
PT (2) PT2699261T (sr)
RS (2) RS57877B1 (sr)
SI (2) SI3404041T1 (sr)
WO (1) WO2012145417A1 (sr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107488228A (zh) 2008-04-11 2017-12-19 中外制药株式会社 与多个分子的抗原反复结合的抗原结合分子
RU2658504C9 (ru) 2010-11-30 2018-08-21 Чугаи Сейяку Кабусики Кайся Антигенсвязывающая молекула, способная многократно связываться с множеством антигенных молекул
WO2016172026A1 (en) * 2015-04-20 2016-10-27 The Board Of Regents Of The University Of Texas System Clec11a is a bone growth agent
US10961305B2 (en) 2016-12-21 2021-03-30 Mereo Biopharma 3 Limited Use of anti-sclerostin antibodies in the treatment of osteogenesis imperfecta
WO2018139623A1 (en) 2017-01-30 2018-08-02 Chugai Seiyaku Kabushiki Kaisha Anti-sclerostin antibodies and methods of use

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5466468A (en) 1990-04-03 1995-11-14 Ciba-Geigy Corporation Parenterally administrable liposome formulation comprising synthetic lipids
US5399363A (en) 1991-01-25 1995-03-21 Eastman Kodak Company Surface modified anticancer nanoparticles
US5543158A (en) 1993-07-23 1996-08-06 Massachusetts Institute Of Technology Biodegradable injectable nanoparticles
IE80468B1 (en) 1995-04-04 1998-07-29 Elan Corp Plc Controlled release biodegradable nanoparticles containing insulin
US6316408B1 (en) * 1997-04-16 2001-11-13 Amgen Inc. Methods of use for osetoprotegerin binding protein receptors
DK0985039T3 (da) 1997-06-12 2008-06-09 Novartis Int Pharm Ltd Kunstige antistof-polypeptider
PT2261335T (pt) 1998-11-27 2017-09-08 Ucb Pharma Sa Composições e métodos para aumentar a mineralização óssea
US20040009535A1 (en) 1998-11-27 2004-01-15 Celltech R&D, Inc. Compositions and methods for increasing bone mineralization
US20030133939A1 (en) 2001-01-17 2003-07-17 Genecraft, Inc. Binding domain-immunoglobulin fusion proteins
MEP2808A (xx) 2003-06-16 2010-02-10 Celltech R & D Inc Antitijela specifična za sklerositin i metode za povećanje mineralizacije kostiju
US8003108B2 (en) * 2005-05-03 2011-08-23 Amgen Inc. Sclerostin epitopes
US7592429B2 (en) 2005-05-03 2009-09-22 Ucb Sa Sclerostin-binding antibody
US20100028335A1 (en) 2007-02-02 2010-02-04 Novartis Ag Compositions and Methods to Treat Bone Related Disorders
US7744874B2 (en) 2007-03-20 2010-06-29 Eli Lilly And Company Anti-sclerostin antibodies
CL2008002775A1 (es) * 2007-09-17 2008-11-07 Amgen Inc Uso de un agente de unión a esclerostina para inhibir la resorción ósea.
TWI489993B (zh) 2007-10-12 2015-07-01 Novartis Ag 骨硬化素（ｓｃｌｅｒｏｓｔｉｎ）抗體組合物及使用方法
EA201000718A1 (ru) 2007-11-02 2011-06-30 Новартис Аг Молекулы и способы, предназначенные для модуляции родственного рецептору липопротеидов низкой плотности белка 6 (lrp6)
WO2010100200A2 (en) 2009-03-05 2010-09-10 Novartis Ag Lyophilised antibody formulation
WO2010100179A2 (en) 2009-03-05 2010-09-10 Novartis Ag Self-forming gel system for sustained drug delivery
WO2010115932A1 (en) 2009-04-08 2010-10-14 Novartis Ag Combination for the treatment of bone loss
WO2010130830A2 (en) 2009-05-15 2010-11-18 Ablynx N.V. Amino acid sequences directed against sclerostin and polypeptides comprising the same for the treatment of bone diseases and disorders

Also Published As

Publication number Publication date
EP2699261B1 (en) 2018-07-11
EP3404041B1 (en) 2020-07-22
CA2833289A1 (en) 2012-10-26
US20140127192A1 (en) 2014-05-08
SI2699261T1 (sl) 2018-11-30
LT2699261T (lt) 2018-11-12
DK3404041T3 (da) 2020-08-24
DK2699261T3 (en) 2018-09-17
EP3404041A1 (en) 2018-11-21
HRP20201366T1 (hr) 2020-11-27
ES2685479T3 (es) 2018-10-09
EP2699261A1 (en) 2014-02-26
AU2012245495A1 (en) 2013-11-07
CY1123513T1 (el) 2022-03-24
PL2699261T3 (pl) 2018-12-31
HUE052094T2 (hu) 2021-04-28
PL3404041T3 (pl) 2020-12-14
CY1121527T1 (el) 2020-05-29
WO2012145417A1 (en) 2012-10-26
PT2699261T (pt) 2018-10-22
ES2823240T3 (es) 2021-05-06
SI3404041T1 (sl) 2020-11-30
LT3404041T (lt) 2020-08-25
RS60835B1 (sr) 2020-10-30
HRP20181649T1 (hr) 2018-12-14
PT3404041T (pt) 2020-07-30

Similar Documents

Publication Publication Date Title
HK1201040A1 (en) Method for treating osteoporosis
PL2685961T3 (pl) Sposób leczenia urazu neurologicznego
ZA201400005B (en) Method for treating eczema
EP2698463A4 (en) WASHING METHOD
GB201118838D0 (en) Process for treating an underground formation
ZA201208219B (en) Method for treating wasterwater
EP2531625A4 (en) PROCESS FOR PROCESSING FRACTURE MATERIALS
EP2650276A4 (en) PROCESS FOR PRODUCTION OF -FLUOROALCOOL
PL2771280T3 (pl) Sposób obróbki skał fosfatowych
EP2716970A4 (en) WASTE MELTING PROCESS
HRP20181649T1 (hr) Metoda liječenja osteoporoze
HK1202297A1 (en) Methods for treating acne
PL2691219T3 (pl) Sposób obróbki tekstyliów technicznych
HK1252353A1 (zh) 治療精神分裂症的方法
GB201119867D0 (en) Method
EP2723348A4 (en) METHOD FOR THE TREATMENT OF ADIPOSITAS
EP2694077A4 (en) METHOD FOR TREATING ASTHENOPY
GB201101219D0 (en) Method
IL228744A0 (en) A method for treating diseases related to interferon alpha
GB201121008D0 (en) Apparatus & method
IL233240A0 (en) A device for treating cuts
EP2676746A4 (en) straightening PROCEDURE
GB201105523D0 (en) Treatment method
GB201111670D0 (en) Method & apparatus
GB201104861D0 (en) Method